Recombinant Anti-Malaria Antigen x Anti-TLR1 Bispecific Antibody (Diabody-Fc) (BSDBF-181)

Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (Diabody-Fc) is a fusion protein of two diabodies connected together by an Fc region. In a diabody, the two scFvs with short linkers are from anti-malaria antigen and anti-TLR1 antibodies. The VH and VL domains form an inter-chain pairing. The diabody with different specificities is fused to the Fc fragment, which results in 2+2 antigen-binding valency and exerts Fc-mediated functions or just extends the half-life. This BsAb can retarget professional antigen-presenting cells (APCs) including DCs or NK cells to malaria antigen. It is designed for the research of Malaria therapy.

Datasheet INQUIRY

Specifications

Targets

Malaria Antigen & TLR1

Type

Constant Domain-extended Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Malaria

Targets

Target 1

Malaria Antigen

Alternative Names

malaria antigen; parasitic protozoans

Target 2

TLR1

Gene ID

7096

UniProt ID

Q15399

Alternative Names

CD281; TIL; TIL. LPRS5; rsc786; TLR1; Toll-like receptor 1; TLR

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "Malaria Antigen & TLR1"

See other bsAb targets related to "Malaria Antigen"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-Malaria Antigen x Anti-TLR1 Bispecific Antibody (Diabody-Fc) (BSDBF-181). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-Malaria Antigen x Anti-TLR1 Bispecific Antibody (Diabody-Fc) (CAT#: BSDBF-181)

Specifications

Targets

Customer Reviews and Q&As